Biobehavioral Influences of Stress and Inflammation on Mucositis in Adolescents and Young Adults with Cancer: Results from a Pilot Study

Overview

Journal J Adolesc Young Adult Oncol

Specialty Pediatrics

Date 2022 Sep 28

PMID 36169621

Authors

Clifton P Thornton

Nancy Perrin

Sharon Kozachik

Nada Lukkahatai

Kathy Ruble

Affiliations

Soon will be listed here.

Abstract

Chemotherapy-induced mucositis is a prevalent and burdensome toxicity among adolescent and young adults (AYAs) with cancer and impedes the delivery of optimal therapy. Its development is not well understood, but baseline stress and inflammation may be contributory factors. This pilot study evaluates stress and inflammation as risk factors for mucositis, identifies effect size estimates, and evaluates the feasibility of a prospective study to investigate mucositis development. Thirty AYAs receiving chemotherapy with substantial risk of mucositis completed baseline stress measures, and serum was collected for inflammatory biomarker analysis. Regression and mediation analyses determined the relationship between stress/inflammation and mucositis. Stress appears to be a significant risk factor for incidence of mucositis (odds ratio 1.13, = 0.125) and predicts total mucositis score (β = 0.281, = 0.023) as well as peak incidence (β = 0.052, = 0.018). Baseline levels of interleukin (IL)-1a and epidermal growth factor (EGF) predicted mucositis development, and EGF and IL-8 may mediate the relationship between stress and mucositis. Findings suggest that stress-induced inflammation exacerbates symptom development. Results from this pilot study inform mucositis symptom models, suggesting that psychosocial and physiologic factors are involved in development. Importantly, this pilot study provides initial effect size estimates, including magnitude and direction of relationships, that are essential to informing larger, more robustly powered studies. High enrollment, low attrition, and minimal missing data in this study suggest this model is feasible for research in this population. Importantly, this work is a first step in identifying new risk factors for mucositis and targets for nurse-led interventions to prevent toxicity development.

References

Harlan L, Lynch C, Keegan T, Hamilton A, Wu X, Kato I . Recruitment and follow-up of adolescent and young adult cancer survivors: the AYA HOPE Study. J Cancer Surviv. 2011; 5(3):305-14. PMC: 3159756. DOI: 10.1007/s11764-011-0173-y. View

Lalla R, Brennan M, Gordon S, Sonis S, Rosenthal D, Keefe D . Oral Mucositis Due to High-Dose Chemotherapy and/or Head and Neck Radiation Therapy. J Natl Cancer Inst Monogr. 2019; 2019(53). DOI: 10.1093/jncimonographs/lgz011. View

Brown T, Gupta A . Management of Cancer Therapy-Associated Oral Mucositis. JCO Oncol Pract. 2020; 16(3):103-109. DOI: 10.1200/JOP.19.00652. View

Curra M, Soares Junior L, Martins M, Santos P . Chemotherapy protocols and incidence of oral mucositis. An integrative review. Einstein (Sao Paulo). 2018; 16(1):eRW4007. PMC: 5968807. DOI: 10.1590/s1679-45082018rw4007. View

Chitapanarux I, Tungkasamit T, Petsuksiri J, Kannarunimit D, Katanyoo K, Chakkabat C . Randomized control trial of benzydamine HCl versus sodium bicarbonate for prophylaxis of concurrent chemoradiation-induced oral mucositis. Support Care Cancer. 2017; 26(3):879-886. DOI: 10.1007/s00520-017-3904-4. View

Tang X, Liu B, Wang X, Yu Q, Fang R . Epidermal Growth Factor, through Alleviating Oxidative Stress, Protect IPEC-J2 Cells from Lipopolysaccharides-Induced Apoptosis. Int J Mol Sci. 2018; 19(3). PMC: 5877709. DOI: 10.3390/ijms19030848. View

Otmani N, Hattad S . Clinical Outcome in Children with Chemotherapy-Induced Mucositis. Semin Oncol Nurs. 2021; 37(3):151160. DOI: 10.1016/j.soncn.2021.151160. View

Shu Z, Zeng Z, Yu B, Huang S, Hua Y, Jin T . Nutritional Status and Its Association With Radiation-Induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma During Radiotherapy: A Prospective Study. Front Oncol. 2020; 10:594687. PMC: 7677572. DOI: 10.3389/fonc.2020.594687. View

Sonis S, Peterson R, Edwards L, Lucey C, Wang L, Mason L . Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol. 2000; 36(4):373-81. DOI: 10.1016/s1368-8375(00)00012-9. View

10.

Sobue T, Bertolini M, Thompson A, Peterson D, Diaz P, Dongari-Bagtzoglou A . Chemotherapy-induced oral mucositis and associated infections in a novel organotypic model. Mol Oral Microbiol. 2018; 33(3):212-223. PMC: 5945319. DOI: 10.1111/omi.12214. View

11.

Hardbower D, Singh K, Asim M, Verriere T, Olivares-Villagomez D, Barry D . EGFR regulates macrophage activation and function in bacterial infection. J Clin Invest. 2016; 126(9):3296-312. PMC: 5004944. DOI: 10.1172/JCI83585. View

12.

Sonis S . The pathobiology of mucositis. Nat Rev Cancer. 2004; 4(4):277-84. DOI: 10.1038/nrc1318. View

13.

Weaver M, Rosenberg A, Tager J, Wichman C, Wiener L . A Summary of Pediatric Palliative Care Team Structure and Services as Reported by Centers Caring for Children with Cancer. J Palliat Med. 2017; 21(4):452-462. PMC: 5915222. DOI: 10.1089/jpm.2017.0405. View

14.

Di Paolo N, Shayakhmetov D . Interleukin 1α and the inflammatory process. Nat Immunol. 2016; 17(8):906-13. PMC: 5152572. DOI: 10.1038/ni.3503. View

15.

Hodes R, Insel T, Landis S . The NIH toolbox: setting a standard for biomedical research. Neurology. 2013; 80(11 Suppl 3):S1. PMC: 3662338. DOI: 10.1212/WNL.0b013e3182872e90. View

16.

Wang L, Huang Z, Huang W, Chen X, Shan P, Zhong P . Inhibition of epidermal growth factor receptor attenuates atherosclerosis via decreasing inflammation and oxidative stress. Sci Rep. 2017; 8:45917. PMC: 5379239. DOI: 10.1038/srep45917. View

17.

Pulito C, Cristaudo A, La Porta C, Zapperi S, Blandino G, Morrone A . Oral mucositis: the hidden side of cancer therapy. J Exp Clin Cancer Res. 2020; 39(1):210. PMC: 7542970. DOI: 10.1186/s13046-020-01715-7. View

18.

Jones V, McIntyre K, Paul D, Wilks S, Ondreyco S, Sedlacek S . Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus-Associated Stomatitis: A Randomized Phase II Study. Oncologist. 2019; 24(9):1153-1158. PMC: 6738305. DOI: 10.1634/theoncologist.2018-0340. View

19.

Basch E, Reeve B, Mitchell S, Clauser S, Minasian L, Dueck A . Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014; 106(9). PMC: 4200059. DOI: 10.1093/jnci/dju244. View

20.

Larsen E, Devidas M, Chen S, Salzer W, Raetz E, Loh M . Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232. J Clin Oncol. 2016; 34(20):2380-8. PMC: 4981974. DOI: 10.1200/JCO.2015.62.4544. View